New Advances in the Management of Pancreatic Cancer
November 9, 2021 | 6:00 - 7:30 pm
Pancreatic cancer is a malignancy with poor prognosis and high mortality. The risk factors can be categorized as those related to individual characteristics, lifestyle and environment, and disease status. During this conference a panel of experts that includes Dr. Horacio Asbun, Dr. Michael Chuong, Dr. Ripal Gandhi and Dr. Govindarajan Narayanan will examine recently published trial data and review their implications to unresectable locally advanced pancreatic cancer care.
TARGET AUDIENCE
Internists, Hospitalists, General Practitioners, Pulmonologists, General Surgeons, Thoracic Surgeons, Obstetricians and Gynecologists, Oncologists, Radiation Oncologists, Nurses, Pharmacists, Respiratory Therapists, Patient Navigators and all other interested healthcare professionals.
LEARNING OBJECTIVES
- Examine recently published trial data and review their implications to unresectable locally advanced pancreatic cancer care.
- Identify and recognize new clinical data that supports total neoadjuvant therapy in pancreatic cancer.
- Recognize the need for gastrointestinal follow-up for pancreatic cancer patients.
PRESENTERS
Dr. Horacio Asbun - Chief of Hepatobiliary & Pancreatic Surgery
Dr. Michael Chuong - Medical Director of the Proton Therapy Center, Physician Director of the MRI-Guided Radiation Therapy Program, and Director of Radiation Oncology Clinical Research
Dr. Ripal Gandhi – Professor of Interventional Radiology, Miami Cancer Institute and Miami Cardiac and Vascular Institute
Dr. Govindarajan Narayanan – Chief of Interventional Oncology
Created by
